Based on the analysis of biological markers in the primary tumor, there are four subtypes based on estrogen receptor (ER)-status, progesterone receptor (PR)-status (PR), human epidermal growth factor receptor 2 (HER2) and proliferation marker Ki67, together with tumor size, histological grade and lymph node engagement [21,22]. This evidence concerns the gene ERBB2 and neoplasm.